Endometriosis currently affects 10% of French women. This pathology, which causes severe chronic pain, does not yet have a treatment.
But a new molecule will soon be available in France and will effectively reduce chronic pain. The treatment, already marketed in the United States since 2018, should arrive in France this year. The advantage of this medication is that it could be prescribed for several years, unlike current similar treatments, which are limited to a few months of use due to serious side effects such as a reduction in bone density.